ConductScience.org, home
Safety and Efficacy of Boceprevir in Previously Untreated Subjects With Chronic Hepatitis C Genotype 1 (Study P05216AM2) (COMPLETED)
API referenceFor AI assistants

Trial · NCT00705432

Participant flow42

How many started, completed or left each group, period by period.

1 to 20 of 42

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Treatment PeriodSTARTEDCohort I - 1. Placebo + PEG + RBV311
Treatment PeriodSTARTEDCohort I - 2. Boceprevir + PEG + RBV - 24 Weeks (RGT)316
Treatment PeriodSTARTEDCohort I - 3. Boceprevir + PEG + RBV - 44 Weeks311
Treatment PeriodSTARTEDCohort II - 1. Placebo + PEG + RBV52
Treatment PeriodSTARTEDCohort II - 2. Boceprevir + PEG + RBV - 24 Weeks (RGT)52
Treatment PeriodSTARTEDCohort II - 3. Boceprevir + PEG + RBV - 44 Weeks55
Treatment PeriodSTARTED BOCEPREVIR/PLACEBOCohort I - 1. Placebo + PEG + RBV297
Treatment PeriodSTARTED BOCEPREVIR/PLACEBOCohort I - 2. Boceprevir + PEG + RBV - 24 Weeks (RGT)303
Treatment PeriodSTARTED BOCEPREVIR/PLACEBOCohort I - 3. Boceprevir + PEG + RBV - 44 Weeks299
Treatment PeriodSTARTED BOCEPREVIR/PLACEBOCohort II - 1. Placebo + PEG + RBV47
Treatment PeriodSTARTED BOCEPREVIR/PLACEBOCohort II - 2. Boceprevir + PEG + RBV - 24 Weeks (RGT)47
Treatment PeriodSTARTED BOCEPREVIR/PLACEBOCohort II - 3. Boceprevir + PEG + RBV - 44 Weeks55
Treatment PeriodCOMPLETEDCohort I - 1. Placebo + PEG + RBV148
Treatment PeriodCOMPLETEDCohort I - 2. Boceprevir + PEG + RBV - 24 Weeks (RGT)205
Treatment PeriodCOMPLETEDCohort I - 3. Boceprevir + PEG + RBV - 44 Weeks190
Treatment PeriodCOMPLETEDCohort II - 1. Placebo + PEG + RBV11
Treatment PeriodCOMPLETEDCohort II - 2. Boceprevir + PEG + RBV - 24 Weeks (RGT)24
Treatment PeriodCOMPLETEDCohort II - 3. Boceprevir + PEG + RBV - 44 Weeks25
Treatment PeriodNOT COMPLETEDCohort I - 1. Placebo + PEG + RBV163
Treatment PeriodNOT COMPLETEDCohort I - 2. Boceprevir + PEG + RBV - 24 Weeks (RGT)111

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00705432/flow

API referenceFor AI assistants